Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Gainor Highlights Future of Immunotherapy in Stage III Lung Cancer Treatment

Ellie Leick
Published: Sunday, Jul 14, 2019

Justin F. Gainor, MD

Justin F. Gainor, MD
The PACIFIC-2 study (NCT03519971) is examining the use and placement of immunotherapy in the treatment of patients with unresectable locally advanced lung cancer, specifically whether it would be most appropriately delivered after chemoradiation or concurrently, explained Justin F. Gainor, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication